4.4 Article

Purification and characterization of a novel lectin from the toxic wild mushroom Inocybe umbrinella

期刊

TOXICON
卷 53, 期 3, 页码 360-366

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.toxicon.2008.12.009

关键词

Lectin; Mushroom; Inocybe umbrinella

资金

  1. National Grants of China [nyhyzx07-008, 2006BAD07A01]

向作者/读者索取更多资源

From the dried fruiting bodies of the toxic mushroom Inocybe umbrinella, a novel lectin with a molecular mass of 17 kDa has been isolated with about 160-fold purification. The purification protocol comprised ion exchange chromatography on DEAE-cellulose, and CM-cellulose, and gel filtration on Superdex 75. Among the carbohydrates tested, raffinose, D-melibiose, a-lactose and D(+)-galactose could inhibit the hemagglutinating activity of the lectin. The hemagglutinating activity was stable between 10 and 60 degrees C, in 12.5-100 mM HCl, and in 50 mM NaOH. The hemagglutinating activity was inhibited by Ca2+, Mn2+ and Mg2+ ions, but was unaffected by Fe3+, Zn2+ and Al3+ ions. The lectin inhibited HIV-1 reverse transcriptase with an IC50 of 4.7 +/- 0.2 mu M. Proliferation of tumor cells including hepatoma HepG2 cells and breast cancer MCF7 cells was inhibited by the lectin with an IC50 of 3.5 +/- 0.2 mu M and 7.4 +/- 0.3 mu M, respectively. The lectin has a unique N-terminal amino acid sequence, DGVLATNAVA. It did not exhibit antifungal activity. The present report is the first on an Inocybe lectin and represents one of the very few reports on lectins from toxic mushrooms. (C) 2008 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
Article Pharmacology & Pharmacy

Assessment of Aflatoxin M1 in human breast and powdered milk in Tehran, Iran

Mohammadhossein Movassaghghazani, Nazanin Shabansalmani

Summary: The study revealed high levels of AFM1 in both breast milk and powdered milk samples in Tehran, with some samples exceeding the established limits. Therefore, monitoring and regulating toxin levels in these products is crucial for maternal and infant health.

TOXICON (2024)

Article Pharmacology & Pharmacy

Integrating network pharmacology and experimental validation to explore the mechanisms of luteolin in alleviating fumonisin B1-induced intestinal inflammatory injury

Defeng Wen, Wantong Han, Quan Chen, Guanhui Qi, Mengling Gao, Pu Guo, Yu Liu, Zhongyuan Wu, Shulin Fu, Qirong Lu, Yinsheng Qiu

Summary: Luteolin can inhibit FB1-induced intestinal inflammatory injury by inhibiting the activation of NF-kappa B and ERK signaling pathways, according to network pharmacology and in vitro experiments.

TOXICON (2024)